RT @drdavidliew: @RheumNow Safety is pretty good too - this is abatacept we are talking about here. Cost is a different
Tweet Content
@RheumNow Safety is pretty good too - this is abatacept we are talking about here. Cost is a different question, as is the pharmacoeconomics, but at least it’s safe. One other thing about the study ⬇️ #EULAR2023
@RheumNow https://t.co/H3AdBsK8t9
Show on Archive Page
On
Display in Search Results
On
PDQ
Off